Trial Profile
Study to Identify Factors associated with Resilience to Clinical Dementia at Old Age
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 28 Feb 2019
Price :
$35
*
At a glance
- Drugs Flutemetamol-F-18 (Primary)
- Indications Alzheimer's disease
- Focus Biomarker; Diagnostic use
- Acronyms 90+ Study
- 28 Feb 2019 Status changed from recruiting to discontinued.
- 02 Aug 2016 New trial record